PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram illustrating the identification, screening, and selection of articles included in this systematic literature review (IMAGE)

Xia & He Publishing Inc.

PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) flow diagram illustrating the identification, screening, and selection of articles included in this systematic literature review

Caption

Eligible studies were original research papers that compared estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) receptor status in primary and recurrent breast cancer, published between 2013 and 2023, and written in English.

Credit

Kylie J. Mansfield

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.